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ABSTRACT
Inflammation is associated with obesity and insulin resistance. Proinflammatory cytokines produced by adipose tissue in obesity could alter insulin signaling and action. Recent studies have shown a relationship between interleukin (IL)-1amount and metabolic syndrome or type 2 diabetes. However, the ability of IL-1 to alter insulin signaling and action remains to be explored. We demonstrated that IL-1 sligthly increased Glut 1 translocation and basal glucose uptake in 3T3-L1 adipocytes. Importantly, we found that prolonged-IL-1 treatment reduced the insulin-induced glucose uptake whereas an acute treatment had no effect.
Chronic treatment with IL-1 slightly decreased the expression of Glut 4 and markedly inhibited its translocation to the plasma membrane in response to insulin. This inhibitory effect was due to a decrease in the amount of IRS-1 but not IRS-2 expression both in 3T3-L1 and human adipocytes. The decrease in IRS-1 amount resulted in a reduction in its tyrosine phosphorylation and in the alteration of insulin-induced PKB activation and AS160 phosphorylation. Pharmacological inhibition of ERK totally inhibited IL-1-induced down regulation of IRS-1 mRNA. Moreover, IRS-1 protein expression and insulin-induced PKB activation, AS160 phosphorylation and Glut 4 translocation were partially recovered following treatment with the ERK inhibitor. These results demonstrate that IL-1reduces IRS-1 expression at a transcriptional level through a mechanism that is ERK dependent and at a posttranscriptional level independently of ERK activation. By targeting IRS-1, IL-1 is capable of impairing insulin signaling and action, and could thus participate in concert with other cytokines, in the development of insulin resistance in adipocytes.
INTRODUCTION
The prevalence of obesity and type 2 diabetes characterised by an insulin resistance has increased considerably in recent years (1) . Although the molecular mechanisms leading to insulin resistance are not fully understood, accumulation of adipose tissue appears to be closely related to the development of insulin resistance (2) . It is now clearly established that adipose tissue is not only a storage organ for excess calories but also an endocrine organ that secretes various factors collectively called adipokines that regulate glucose homeostasis, food intake, and energy expenditure (2) . It has been recently determined that obesity and insulin resistance are associated with a low-grade chronic systemic inflammation. The origin of this inflammation could be related to adipose tissue expansion because the expression of proinflammatory cytokines including TNF-, IL-1 and IL-6 is increased in this tissue in obese state (3, 4) . Increased macrophage population in adipose tissue is thought to be responsible for this elevated production of cytokines (5, 6) . Proinflammatory cytokines produced in adipose tissue could alter the endocrine function of the tissue and could impinge insulin signaling and action in adipocytes, liver and muscles leading to the development and/or the aggravation of insulin resistance (4).
Insulin regulates blood glucose level through suppression of hepatic endogenous glucose production and stimulation of glucose uptake in muscle and adipocyte. These biological responses require the tyrosine phosphorylation of the IRS-1 and /or IRS-2 proteins that in turn bind and activate PI 3-kinase. Downstream effectors of PI 3-kinase such as protein kinase B (PKB) are involved in insulin metabolic effects (7) . Several reports have shown that TNF- and IL-6 alter insulin signaling by targeting IRS-1 proteins. TNF- increases the serine phosphorylation of IRS-1. This mechanism reduces its tyrosine phosphorylation by the insulin receptor (8) (9) (10) and several kinases including JNK (11), mTOR (12, 13) and ERK (13) (14) (15) have been implicated in the serine phosphorylation of IRS-1. TNF- and IL-6 also enhance the expression of SOCS (Suppressor of Cytokine Signaling) proteins that can attenuate insulin signaling by binding to the insulin receptors and reducing their ability to phosphorylate IRS proteins (16, 17) . Alternatively, SOCS proteins can bind directly to IRS proteins leading to their degradation (18, 19) . Finally, TNF- and IL-6 could inhibit IRS-1 expression at the transcriptional level (20) (21) (22) . In obesity, alteration of IRS-1 tyrosine phosphorylation in muscle is not linked to a change in its expression. By contrast, a downregulation of IRS-1 mRNA expression seems to be the major mechanism involved in alteration in IRS-1 tyrosine phosphorylation in adipocytes of obese rodents and in adipocytes from type 2 diabetic subjects, obese patients and relatives of diabetic subjects (23, 24) .
Whereas the implication of TNF- and IL-6 insulin resistance is well documented, little is known about a potential role of IL-1. IL-1 is one of the major pro-inflammatory cytokines that is produced by monocytes and macrophages (25) . IL-1 exerts its biological function by binding to IL-1 type I receptor and activates the IKK/NF-B pathway and the three types of mitogen-activated protein (MAP) kinases ERK, JNK and p38MAPK (25) . Recent studies suggest that IL-1 could also belong to the network of cytokines involved in insulin resistance. Indeed, in a case/control study, individuals with detectable circulating levels of IL-1and elevated levels of IL-6 have an increased risk to develop type 2 diabetes compared with individuals with increased concentrations of IL-6 but undetectable levels of IL-1 (26) .
Further, IL-1 concentration is elevated in non-diabetic offspring of diabetic individuals and is correlated with the metabolic syndrome (27) . Finally, expression of both IL-1and its receptor is increased in visceral adipose tissue of obese subjects (28).
However, whether and how this overproduction of IL-1 could alter the metabolic function of insulin in adipocytes remains unclear. In the present study, we found that IL-1 markedly inhibits insulin-induced glucose transport in adipocytes by decreasing IRS-1 expression.
Further, we demonstrate that activation of the ERK pathway is involved in the inhibitory action of IL-1on insulin signaling. Cells culture-3T3-L1 fibroblasts were grown at 7 % CO 2 and 37 C in 35 or 100 mm dishes in DMEM, 25 mM glucose, 10% calf serum, and induced to differentiate in adipocytes as previously described (13) . Briefly, 2 days after confluence, medium was changed for DMEM, 25 mM glucose, 10% fetal calf serum (FCS), supplemented with isobutylmethylxanthine (0.25 mM), dexamethasone (0.25 µM), insulin (5 µg/ml), and pioglitazone (10 µM). The medium was removed after 2 days and replaced with DMEM, 25 mM glucose, 10% FCS, supplemented with insulin (5 µg/ml) and pioglitazone (10 µM) for 2 days. Then, the cells were fed every 2 days with DMEM, 25 mM glucose, 10% FCS. 3T3-L1 adipocytes were used 8-15 days after the beginning of the differentiation protocol.
MATERIAL AND METHODS

Materials-
Human preadipocytes (Biopredic, Rennes, France) were grown at 5% CO2 and 37 C in 12- mM NaCl, 10 mM EDTA, 100 mM NaF, 10 mM pyrophosphate, 2 mM sodium orthovanadate) before solubilization for 1 hour at 4°C in lysis buffer (20 mM Tris pH 7.4, 150 mM NaCl, 10 mM EDTA, 100 mM NaF, 10 mM pyrophosphate, 2 mM sodium orthovanadate, 100 nM okadaic acid, protease inhibitors, and 1% Triton X-100 (v/v)).
Following centrifugation at 14 000 g for 10 min at 4 C, the supernatant (cells lysates) was incubated for 4 hours at 4 C with antibody of interest (5-10 µg/sample) preadsorbed on protein-A-Sepharose beads. The beads were washed 3 times with the lysis buffer and boiled for 5 min in Laemmli buffer. The proteins were separated by SDS-PAGE using a 7.5 or 10% resolving gel. Proteins were transferred to PVDF membrane and the membrane was blocked with saline buffer (10 mM Tris pH 7.4, 320 mM NaCl, 0.1 % Tween) containing 5% (w/v) non-fat dry milk for 1 hour at room temperature and incubated overnight at 4 C with the indicated antibody. Following incubation with horseradish-peroxydase conjugated secondary antibodies, proteins were detected by enhanced chemiluminescence (ECL). Some membranes were subsequently incubated at 55 C for 30 min in stripping buffer (62 mM Tris pH 6.7, 100 mM 2-mercaptoethanol, and 2% SDS) and reprobed with the indicated antibody. 
Preparation of plasma membrane sheets and immunofluorescence labelling-3T3-L1 cells
were grown on glass coverslips and differentiated into adipocytes as described above. Cells were treated without or with IL-1β at 20 ng/ml for 48 hours, and stimulated or not with insulin (100 nM) for 20 min. Plasma membrane sheets were prepared as previously described (30) . Cells were washed twice with ice-cold PBS, and fixed with 0.55 mg/ml Poly-L-lysine 
RESULTS
Effect of acute and chronic IL1- treatments on insulin-induced glucose transport in 3T3-L1
adipocyte-The likelihood that 3T3-L1 adipocytes are target cells for IL-1 was investigated by incubating 3T3-L1 adipocytes with IL-1 for 20 min. IL-1 incubation induced the degradation of IB and the phosphorylation of the MAP kinases ERK, JNK and p38MAPK (Fig. 1A) . These data indicate that 3T3-L1 adipocytes are responsive to IL-1 stimulation.
We then determined whether IL-1was able to induce an insulin-resistant state for glucose transport in 3T3-L1 adipocytes. Cells were incubated with IL-1 (20 ng/ml) and then incubated without or with insulin ( 0.5 or 100 nM). Treatment of 3T3-L1 adipoytes with IL1for 20 min slightly increased the basal rate of glucose uptake but did not modify insulininduced glucose uptake (Fig. 1B, upper panel) . Importantly, IL-1 treatment of 3T3-L1
adipocytes for 48 h reduced the absolute response at both insulin concentration (Fig. 1B,   lower panel) . Thus, the increment in glucose uptake at 0.5 nM insulin was 3.91 + 0.21 and 
Effect of IL-1 on glucose transporters expression and insulin-induced glucose transporters
translocation-We first examined whether the inhibitory effect of IL-1 on glucose uptake was due to a change in glucose transporters expression. 3T3-L1 adipocytes were treated without or with IL-1 for 48 h and the amount of Glut 1 and Glut 4 in cell lysate was quantified by immunoblotting with specific antibodies. As shown in Fig. 2A , IL-1 treatment increased the amount of Glut 1 and slightly decreased Glut 4 expression but did not modify the differentiation state of adipocyte because C/EBP PPARand aP2 mRNAs expression was not altered (Fig. 2B) . The increased Glut 1 expression induced by IL-1 was associated with an increase in the amount of the transporter at the plasma membrane (Fig. 2C, left panel) and could explain the enhancement of glucose uptake induced by IL-1 alone. Importantly, prolonged IL-1treatment did not modify the basal amount of Glut 4 at the plasma membrane but inhibited by 50 % the amount of Glut 4 at the plasma membrane following insulin stimulation. (Fig. 2C, right panel) . These results indicated that IL-1 can trigger an insulin resistant state for glucose transport by altering insulin-induced Glut 4 translocation.
Differential effect of IL-1 on insulin-induced tyrosine phosphorylation of IRS proteins-
Because IL-1 altered insulin-induced Glut4 translocation, we studied the effect of the cytokine on proximal insulin signaling steps involved in this process. We first analyzed the effect of IL-1 on the insulin receptor tyrosine phosphorylation. 3T3-L1 adipocytes were pretreated or not with 20 ng/ml IL-1 for 48 h and then stimulated or not with insulin. The insulin-induced tyrosine phosphorylation of the insulin receptor, which was analyzed by immunoblotting using anti-phosphotyrosine antibodies, was not altered following IL1treatment (Fig. 3) . We then determined whether IL-1 could alter the insulin-induced IRS tyrosine phosphorylation. IRS-1 or IRS-2 were immunoprecipitated from 3T3-L1 adipocytes with specific antibodies and their tyrosine phosphorylation was quantified by immunoblotting with anti-phosphotyrosine antibody. As shown in Fig. 3 , IL-1 alone did not induce IRS-1 or IRS-2 tyrosine phosphorylation. Importantly, IL-1 inhibited insulin-induced IRS-1 tyrosine phosphorylation by 60% but did not modify insulin-induced IRS-2 tyrosine phosphorylation.
In parallel to the decrease in IRS-1 tyrosine phosphorylation, less IRS-1 was immunoprecipitated in IL-1-treated cells suggesting that IL-1 could alter IRS-1 expression.
To directly assess this possibility, we analyzed IRS-1 expression in homogenates prepared from 3T3-L1 adipocytes treated for 24 or 48h with IL-1. IL-1 decreased IRS-1 protein expression by 50% and 60% at 24 and 48 h, respectively (Fig. 4A ) whereas IRS-2 amount was unchanged (data not shown).
Because IRS-1 amount is dramatically decreased in adipocytes of obese patients, we investigated whether IL-1 could also down-regulate IRS-1 expression in human adipocytes.
As shown in Fig. 4A , IL-1 markedly reduced IRS-1 amount in human adipocytes suggesting that IL-1 could participate in the negative regulation of IRS-1 in adipocyte of obese subjects.
We then found, by using real-time PCR, that IL-1 treatment decreased IRS-1 mRNA amount by 40% (Fig 4B) indicating that the decrease in IRS-1 protein was partly linked to a reduced gene expression. In agreement with these in vitro finding, IL-1 mRNA expression was increased in two models of obese mice and IRS-1 mRNA was decreased whereas IRS-2 mRNA level was not markedly reduced (Fig. 5 ).
Taken together, these results indicate that IL-1 specifically reduced the amount of IRS-1 leading to a decrease in the amount of tyrosine phosphorylated IRS-1 following insulin stimulation.
IL-1 is more potent than IL-6 to inhibit IRS-1 expression-Because IL-1 increases IL-6
production in fat cells (31) and because IL-6 was shown to down-regulate IRS-1 expression (20), we compared the ability of IL-1 and IL-6 to regulate IRS-1 expression. Treatment of 3T3-L1 adipocytes with IL-6 (20 ng/ml) for 24 h slightly decreased IRS-1 amount whereas in the same conditions, IL-1 induced a 50% inhibition in IRS-1 expression (Fig. 4C ). These data indicate that IL-1 is more potent than IL-6 to down-regulate IRS-1 expression and from these data, it is unlikely that the observed effect on IRS-1 expression is mediated by an increase in IL-6 production.
Insulin-induced PKB activation and AS160 phosphorylation are reduced in IL-1 treated 3T3-L1 adipocytes-Activation of PKB following tyrosine phosphorylation of IRS-1 or IRS-2
is a critical step for insulin-induced glucose transport and Glut 4 translocation (7). Because IL-1 differentially regulated the expression and the tyrosine phosphorylation of these proteins, we aimed at determining the effect of IL-1 treatment on insulin-induced PKB activation. PKB activation was monitored by immunoblotting with a phosphospecific antibody against Threonine 308 located in the activation loop of PKB, phosphorylation which correlates with PKB activation. Importantly, following IL-1 treatment, the insulin-induced phosphorylation of PKB was reduced by 50% without any change in the total amount of PKB (Fig. 6 ). We then assessed the effect of IL-1 on phosphorylation of the PKB substrate AS160 (Akt substrate 160). Indeed, PKB-induced phosphorylation of AS160, a protein containing a Rab GAP (GTPase activating protein) domain promotes Glut 4 translocation to the plasma membrane (32, 33) . Using a phosphospecific antibody against the PKB phosphorylation site on AS160, we found that IL-1 treatment markedly reduced insulininduced AS160 phosphorylation (Fig. 6 ). This data confirmed that PKB activity was reduced following IL-1 treatment, and the reduced AS160 phosphorylation may provide a mechanism for IL-1-induced insulin resistance on Glut 4 translocation and glucose uptake. 
ERK pathway is involved in IL-1 induced alteration in insulin signaling-
DISCUSSION
Recent studies demonstrate that expression of IL-1 is increased in adipose tissue of both obese rodents and humans (28), an observation that we confirmed in this study. However whereas the involvement of TNF and IL-6 in insulin resistance is well documented, the potential role of IL-1 in the alteration of insulin signaling and metabolic effects is poorly documented.
In the present study, no acute inhibitory effect of IL-1 was observed on insulin-induced glucose uptake or on insulin signaling in accordance with a recent report with IL-1(34).
By contrast, in the  pancreatic cell line RINm5F, IL-1 was shown to rapidly induce SOCS-3 expression that evoked a decrease in insulin receptor phosphorylation and IRS phosphorylation (35) . Moreover, the effect of IL-1 is clearly different from the TNFeffect that promotes a rapid inhibition of IRS-1 tyrosine phosphorylation through its serine phosphorylation (11, 36) .
We found that prolonged IL-1 treatment induces an inhibition of insulin effect on glucose uptake as also recently published (37) during the revision process of this manuscript. A sustained increase in the expression of IL-1 in adipose tissue during obesity could thus participate in the development of the insulin resistance. This inhibitory effect was mainly due to the down-regulation of the expression of IRS-1 and to a lesser degree of Glut 4. TNF and IL-6 have also been shown to negatively regulate the expression of these two proteins (20) (21) (22) . However, whereas TNF markedly suppressed Glut 4 expression (20), we found that IL-1 had only a modest effect. Further, upon prolonged exposure to TNF, mature adipocytes loose their terminally differentiated phenotype whereas we found no effect of IL-1 on PPARor C/EBP mRNAs expression in our experimental conditions indicating that IL-1
did not induce a change in the differentiation state of the 3T3-L1 adipocytes. In agreement with these findings, it was recently reported that treatment of mature 3T3-L1 adipocytes with IL-1 for 6 days did not modify their differention state (37) whereas addition of the cytokine during the differentiation process markedly altered the adipocyte phenotype (37, 38) .
IL-1 increases the expression of IL-6 in fat cells (31) but it seems unlikely that the inhibition of IRS-1 expression was totally mediated by IL-6. Indeed, we found that a high level of IL-6 modestly decreased IRS-1 expression compared to IL-1. By contrast, IL-6 was more potent than IL-1 to decrease Glut 4 and PPAR expression (20, 21) suggesting that IL-1 could regulate IRS-1 expression independently of its effect on IL-6 expression.
Whereas, IRS-1 amount was decreased following IL-1 treatment, the expression of IRS-2 was unchanged. Despite normal IRS-2 amount and tyrosine phosphorylation, we found that insulin-induced PKB activation was markedly altered leading to a decreased phosphorylation of its substrate AS160, a Rab GTPase-activating protein recently described to play a role in insulin-stimulated Glut 4 translocation (32, 33) . These data support that IRS-1 rather IRS-2 is involved in insulin-induced glucose uptake. In agreement with this finding, previous studies have shown that insulin-induced glucose uptake is altered in adipocytes from IRS-1 deficient mice (39) . Further, in L6 myotube, knockdown of IRS-1 by siRNA strategy markedly impaired glucose transport, and knockdown of IRS-2 was without effect (40) .
Elevated activities of the MAP kinases ERK, JNK and p38MAPK are found in adipocytes or muscles of obese and insulin resistant rodent and humans (8) and IL-1 is known to activate these protein kinases (25) . We found that prolonged IL-1 treatment induced a sustained activation of ERK and p38MAPK but not JNK suggesting that an increase in IL-1 expression in adipose tissue could thus participate in the elevated activity of these kinases in obesity. Such activation of these kinases could be involved in the inhibitory effect of IL-1 
